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Abstract: Stroke volume variation (SVV) has been used to predict fluid responsiveness; however,
it remains unclear whether goal-directed fluid therapy using SVV contributes to bowel function
recovery in abdominal surgery. This prospective randomized controlled trial aimed to compare
bowel movement recovery in patients undergoing colon resection surgery between groups using
traditional or SVV-based methods for intravenous fluid management. We collected data between
March 2015 and July 2017. Bowel function recovery was analyzed based on the gas-passing time,
sips of water time, and soft diet (SD) time. Finally, we analyzed data from 60 patients. There was
no significant between-group difference in the patients’ characteristics. Compared with the control
group (n = 30), the SVV group (n = 30) had a significantly higher colloid volume and lower crystalloid
volume. Moreover, the gas-passing time (77.8 vs. 85.3 h, p = 0.034) and SD time (67.6 vs. 85.1 h,
p < 0.001) were significantly faster in the SVV group than in the control group. Compared with
the control group, the SVV group showed significantly lower scores of pain on a numeric rating
scale and morphine equivalent doses during post-anesthetic care, at 24 postoperative hours, and at
48 postoperative hours. Our findings suggested that, compared with the control group, the SVV group
showed a faster postoperative SD time, reduced acute postoperative pain intensity, and lower rescue
analgesics. Therefore, SVV-based optimal fluid management is expected to potentially contribute to
postoperative bowel function recovery in patients undergoing colon resection surgery.
Keywords: colon cancer surgery; goal-directed fluid therapy; recovery; bowel movement; stroke
volume variation
1. Introduction
Traditionally, fluids are administered during intestinal resection based on several
factors, including preoperative fasting time, intraoperative bleeding, blood pressure main-
tenance, and loss of one-third volume of water. In cases with a wide resection range or a
long surgical duration, hypovolemia may reduce tissue perfusion and causes detrimental
organ dysfunctions. However, excessive intraoperative fluid administration also leads to
poor outcomes, including increased postoperative bowel edema, respiratory complications,
and longer durations of hospital stay. Therefore, goal-directed fluid supply is warranted
since optimal intraoperative supply of fluids improves postoperative recovery and prog-
nosis [1–3]. Unfortunately, optimal fluid replacement therapy during major abdominal
surgery remains unclear.
During the perioperative period, there are possible negative or positive interactions
between fluid therapy and gastrointestinal (GI) function. Inadequate fluid management
J. Clin. Med. 2021, 10, 1857. https://doi.org/10.3390/jcm10091857 https://www.mdpi.com/journal/jcm
J. Clin. Med. 2021, 10, 1857 2 of 10
may cause delayed GI function recovery and may thus prevent early oral intake. More-
over, postoperative GI dysfunction may cause electrolyte loss and metabolic problems [3].
For precise measurement of adequate intravascular volume, central venous pressure, pul-
monary artery occlusion pressure, the intrathoracic blood volume index, and the left
ventricular end-diastolic volume index were introduced; however, these often fail to pro-
vide reliable information or to predict fluid responsiveness and often provide conflicting
reports [4–6]. Consequently, viewing the fluid response through SVV after catheter inser-
tion through the radial artery is a more widely used method [7,8]. Stroke volume variation
(SSV) refers to differences in stroke volume during the respiratory cycle. It can be indirectly
measured through arterial pressure waveform analysis on an EV1000™ monitor using the
Flo Trac VigiloTM. SVV has been performed to predict the degree of fluid responsiveness
in abdominal surgery [9,10]. In addition, Asklid D et al. reported that goal-directed fluid
management improves long-term survival after colorectal cancer surgery [11]. On the other
hand, a separate meta-analysis concluded that goal-directed fluid management does not
improve postoperative GI function recovery [12]. Therefore, the utility of SVV in improving
postoperative bowel movement recovery remains unclear.
We hypothesized that intraoperative goal-directed fluid management could maintain
the optimal intravascular volume status in patients with abdominal surgery and could sub-
sequently help recover postoperative bowel function. Accordingly, we aimed to compare
SVV-based and conventional fluid management in terms of bowel movement recovery
after colorectal cancer surgery.
2. Materials and Methods
2.1. Study Population
This was a single-center, prospective, randomized controlled clinical trial. The pro-
tocol was approved by the ethical standards of the Severance Hospital Research Ethics
Committee and Institutional Review Board (IRB number: 4-2014-0730); moreover, it was
registered at clinicalTrials.gov (NCT02288767). This study was conducted according to
the World Medical Association Declaration of Helsinki. All patients provided written
informed consent before study enrolment. Using the American Society of Anesthesiolo-
gists’ physical status I–III, we assessed adult patients who underwent elective colorectal
cancer surgery at our tertiary hospital between March 2015 and August 2017 for eligibility.
The exclusion criteria were an unexpected surgical plan change, consent retraction, a pre-
operative left ventricular ejection fraction <40%, significant cardiac arrhythmias or valve
regurgitation, coagulation disorders (activated partial thromboplastin time >1.5 times nor-
mal value), preoperative renal insufficiency (serum creatinine >2 mg/dL, oliguria, anuria,
or hemodialysis), impaired hepatic function (phosphatase alkaline, aspartate aminotrans-
ferase, and alanine aminotransferase >2 times normal values), preoperative infection,
current pregnancy, and participation in another trial.
A computer-generated randomization table was used to randomly allocate patients
to either the SVV group (patients undergoing intraoperative fluid management with SVV
guidance) or the control group (patients undergoing conventional intraoperative fluid
management) in a 1:1 ratio, and copies of the random sequence were kept in sealed,
opaque envelopes. Randomization was not blocked or stratified. Only the investigator
who performed the intervention in the operating room was aware of the allocation group,
with the patients and other outcome researchers being blinded to the group allocation.
Upon the patient’s arrival to the operating room, an electrocardiogram and pulse
oximeter were attached, followed by noninvasive blood pressure measurement. For anes-
thesia induction, 1.5–2.0 mg/kg of propofol was injected with continuous remifentanil
infusion at 0.2 mcg/kg/min. After the administration of 0.8 mg/kg of rocuronium for
muscle relaxation, endotracheal intubation was performed. Depending on the surgery
type and scope, additional venous catheterization was established; moreover, monitor-
ing of blood pressure and laboratory tests were performed with arterial catheterization.
Based on the assigned group, the patients underwent or did not undergo SVV monitor-
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ing using the FloTrac/EV1000™ monitor. Anesthesia was maintained using 50% oxygen,
desflurane, remifentanil, and rocuronium. To determine the appropriate anesthesia depth,
the bispectral index (BIS) was measured and maintained at a level of 40–60. Additionally,
the remifentanil infusion rate was adjusted within 0.05 to 0.5 mcg/kg/min to maintain the
intraoperative blood pressure and pulse rate within 20% of their basal values.
Intraoperative fluid management was performed based on the assigned group. De-
pending on the patient, the fluids were administered based on the preoperative fasting
time, intraoperative fluid loss (evaporation, shedding, urination, surgery site, etc.), and ex-
pected blood loss. The intraoperatively maintained fluid was crystalloid in both groups at
about 4 mL/kg/h. In the SVV group, bolus colloid (single bolus: 100–200 mL, maximal
30 mL/kg) was administered when SVV >12%, but crystalloid or colloid was empirically
administered in the control group. The main crystalloid was lactate linger solution, and the
colloid was hydroxyethyl starch (HES 130/0.4). In case hypotension (MBP falling to less
than 65 mmHg within 5 min) occurred for SVV <12%, a vasoconstrictor was intermittently
injected or continuously infused. In the control group, the crystalloid and colloid (max:
30 mL/kg) were administered based on conventional parameters: blood pressure, heart
rate, output volume, and the anesthesiologist’s preference. Since mechanical respiration is
a confounding factor of SVV, a tidal volume of 8 mL/kg and the positive end-expiratory
pressure (PEEP) were unified as ‘0′. Thirty minutes before the expected end of the surgery,
1.0 g of propacetamol and 0.075 mg of palonosetron were intravenously infused for post-
operative pain control and nausea prevention, respectively. At operation end, desflurane
and remifentanil administration were terminated; furthermore, muscle relaxation was eval-
uated through a train-of-four test using a nerve stimulator and reversed using 0.2 mg of
glycopyrrolate and 1.0 mg of neostigmine. After extubation, the patients were transferred
to the post-anesthetic care room (PACU).
During PACU stay, pain was evaluated using a 10-point numeric rating scale; more-
over, the rescue analgesic consumption was recorded as the morphine equivalent dose.
Furthermore, we assessed the patient’s nausea incidence and consumed antiemetics. In ad-
dition, follow-up measurements of the pain intensity score as well the consumption of
rescue analgesics and antiemetics were obtained at 6, 24, and 48 postoperative hours.
The sips of water (S.O.W), gas-passing, and soft diet times were used to analyze bowel
function recovery. Moreover, we evaluated the occurrence and types of postoperative com-
plications, whether the patient was transferred to the intensive care unit (ICU), the number
of days of postoperative hospital stay, and whether the patient died within the study period
(from March 2015 and August 2017).
2.2. Statistical Analyses
A previous study [13] suggested that the gas-passing time of patients undergoing
colorectal resection surgery was approximately 64 h. Based on the alpha, power, and drop-
out rates of 0.05, 90%, and 15%, respectively, the number of participants per group was
30; consequently, the total sample size was 60 participants. Our primary outcome was to
investigate the postoperative GI function recovery using the gas-passing time, and the SD
and S.O.W start times. The secondary outcomes were other postoperative recovery profiles
such as postoperative pain and nausea, surgical complications, and length of stay. At a
significance level of 5%, all hypotheses underwent two-tailed testing. All continuous and
nominal variables were expressed as mean ± standard deviation (or median [IQR]) and
n (%), respectively. After the Kolmogorov–Smirnov and Shapiro–Wilk tests for normality
assumption, continuous and categorical variables were analyzed using the Student t-test
(or Mann–Whitney U nonparametric test) and Fisher’s exact test, respectively. Statistical
significance was set at p < 0.05. All statistical analyses were performed using SPSS (SPSS
version 23.0; IBM Corp., Armonk, NY, USA).
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3. Results
We enrolled 62 patients who underwent colorectal cancer surgery between March 2015
and August 2017. One patient did not meet the inclusion criteria, while another patient
in the control group dropped out after randomization due to an unexpected surgical plan
change; finally, 60 patients were analyzed (Figure 1).
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Figure 1. CONSORT diagram.
Table 1 shows the patient demographic data. There were no significant between-group
differences in age, gender, physical status, comorbidities, surgical procedures, surgical
duration, and patent-controlled analgesia type.




(N = 30) p-Value
Age (year) 57.9 (6.1) 60.3 (8.9) 0.077
Gender (M/F) 17 (13) 24 (6) 0.095
Height (cm) 163.0 (9.3) 164.6 (6.7) 0.722
Weight (kg) 63.6 (15.5) 65.5 (12.8) 0.829









(N = 30) p-Value
Comorbidity
Hypertension 12 14 0.795
Diabetes Mellitus 3 4 >0.999
Cardiovascular 4 1 0.353
Respiratory 5 5 >0.999
Neurologic 1 0 >0.999
Liver 0 1 >0.999
Kidney 1 4 0.353
Anesthetic duration (min) 285 (66.5) 261.2 (88.9) 0.074





Right hemicolectomy 7 8
Anterior resection 9 12
Low anterior resection 13 8
Left hemicolectomy 0 1
Total colectomy 1 1
Patient-controlled analgesia (via) >0.999
Intravenous 27 27
Epidural 3 3
Table 2 lists the intraoperative parameters, including fluid management. There were
no significant between-group differences in the blood test results, including vital signs,
of in the number of patients who were intraoperatively administered with vasoconstrictors,
in the amount of bleeding, and in urine output. However, there were significant between-
group differences in the amounts of colloid (851.2 ± 461.8 mL vs. 616.7 ± 313.0 mL,
p < 0.001) and crystalloid (806.0 ± 898.6 mL vs. 1615.8 ± 814.8 mL, p = 0.033) administered.




(N = 30) p-Value
Initial vital signs
HR (BPM) 71.6 (11.8) 70.3 (11.3) 0.834
MBP (mmHg) 82.4 (13.7) 86.5 (12.8) 0.181
SpO2 (%) 100 (0) 100 (0) >0.999




Bradycardia event 1 0 >0.999
Laboratory values at baseline
PH 7.443 (0.03) 7.435 (0.04) 0.315
PO2 194.0 (43.4) 194.1 (54.3) 0.806
PCO2 33.3 (4.8) 34.6 (4.0) 0.126
Hematocrit 11.3 (1.6) 11.6 (1.5) 0.246
Lactate 0.83 (0.2) 0.80 (0.2) 0.414
Laboratory values at surgery end
PH 7.428 (0.10) 7.401 (0.04) 0.305
PO2 175 (31.5) 184.1 (31.1) 0.265
PCO2 34.9 (3.8) 37.1 (4.4) 0.054
Hematocrit 11.3 (1.4) 11.4 (1.4) 0.777
Lactate 0.90 (0.3) 0.85 (0.2) 0.419





(N = 30) p-Value
Input
Crystalloid (mL) 1615.8 (814.8) 806.0 (898.6) 0.033
Colloid (mL) 616.7 (313.0) 851.2 (461.8) <0.001
RBC (mL) 41.7 (160.9) 16.7 (57.7) 0.901
Output
Urine (mL) 397.0 (311.1) 459.8 (403.7) 0.545
Bleeding (mL) 159.0 (278.1) 93.3 (182.7) 0.078
Table 3 presents the postoperative pain intensity and consumption of rescue analgesics,
including antiemetics. In the post-anesthesia recovery room, the SVV group showed
significantly lower pain intensity scores than the control group (3.3 ± 1.1 vs. 4.3 ± 1.2,
p = 0.001). Additionally, the pain intensity scores at 6, 24, and 48 postoperative hours were
significantly lower in the SVV group (3.3, 3.8, and 4.1) than in the control group (4.3, 4.5,
and 5.1). Furthermore, the SVV group showed lower rescue analgesic consumption up to
24 h than the control group (p = 0.025). There was no significant between-group difference
in the number of patients receiving antiemetics.




(N = 30) p-Value
Post-Anesthetic Care Unit
Numeric Rating Scale (Pain) 4.3 (1.2) 3.3 (1.1) 0.001
Morphine equivalent dose (mg) 32.2 (38.8) 16.7 (27.3) 0.108
Antiemetic requirement 1 0 0.483
Stay duration (min) 45.1 (11.7) 40.0 (10.5) 0.077
Postoperative 1–6 h
Numeric Rating Scale (Pain) 4.5 (1.1) 3.8 (1.0) 0.033
Morphine equivalent dose (mg) 60.0 (46.8) 46.7 (41.4) 0.285
Antiemetic requirement 14 20 0.192
Postoperative 6–24 h
Numeric Rating Scale (Pain) 5.1 (1.7) 4.1 (1.5) 0.018
Morphine equivalent dose (mg) 101.5 (86.6) 56.7 (58.3) 0.025
Antiemetic requirement 15 19 0.435
Postoperative 24–48 h
Numeric Rating Scale (Pain) 4.2 (1.4) 3.0 (1.1) 0.002
Morphine equivalent dose (mg) 61.7 (71.5) 28.3 (40.9) 0.061
Antiemetic requirement 2 1 >0.999
Table 4 demonstrates the results of our primary endpoint. Compared with the con-
trol group, the SVV group showed a significantly faster soft diet time (67.6 ± 17.1 h vs.
85.1 ± 16.8 h, p = 0.034) and gas-passing time (77.8 ± 36.6 h vs. 85.3 ± 18.5 h, p < 0.001).
The most common postoperative complication was fever, which was controlled using an-
tipyretics and ice bag application. Intra-abdominal infections in two patients were treated
using antibiotic management; moreover, pneumonia and asthma-like respiratory complica-
tions in two patients subsided after supplying nasal O2 and using a nebulizer. Regarding
cardiovascular problems, one patient had suspected ischemic heart disease based on an
electrocardiogram; however, it was checked at a post-discharge follow-up and did not
present any events. Regarding wound problems, one patient showed seroma formation,
which was controlled through wound dressing and antibiotic management. One patient
in each group presented postoperative ileus, with that in the SVV group being surgically
resolved. One patient with suspected anastomosis site leakage and another with dyspepsia
spontaneously recovered and were discharged from the hospital. There were four patients
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in the control group with postoperative acute kidney injury based on the “RIFLE (Risk,
Injury, Failure, Loss, and End stage) criteria, which spontaneously recovered through hy-
dration. There was no between-group difference in the postoperative hospital stay duration
(average eight days); moreover, three patients in the control group were transferred to the
ICU while one patient died in each group within the study period. Overall, there were no
significant between-group differences in the incidence of postoperative complications.




(N = 30) p-Value
Bowel movement recovery
Sips of water time (h) 42.4 (11.6) 37.3 (11.7) 0.051
Soft diet time (h) 85.1 (16.8) 67.6 (17.1) <0.001
Gas passing time (h) 85.3 (18.5) 77.8 (36.6) 0.034
Postoperative Complications
Total cases 15 22 0.110
Fever (>38 ◦C) 12 20 0.069
Intra-abdominal infection 1 1 >0.999
Respiratory 0 2 >0.999
Cardiovascular 0 1 >0.999
Ileus 1 1 >0.999
Wound problem 1 0 >0.999
Anastomosis leakage 0 1 >0.999
Dyspepsia 0 1 >0.999
Kidney injury 4 0 0.112
Reoperation 0 1 >0.999
Postoperative length of stay in hospital 8.1 (5.7) 7.9 (3.8) 0.925
Postoperative intensive care unit
transfer 3 0 0.237
Death 1 1 >0.999
4. Discussion
This study evaluated the utility of SVV for intraoperative fluid management in patients
undergoing colorectal cancer surgery by comparing prognosis, including intestinal motility
recovery and surgical complications. Compared with the control group, the SVV group
showed significantly faster gas-passing and soft diet start times. In contrast to previous
studies assessing abdominal surgery, we only targeted patients with colorectal cancer
surgery and minimized the specific surgery effects; moreover, we focused on postoperative
clinical recovery, with bowel movement recovery as our primary endpoint. Since colorectal
surgery patients may present acute alterations in volume status, precise fluid and electrolyte
administration is critical for their overall perioperative management, which critically affects
postoperative morbidity and mortality. Perioperative fluid management seeks to achieve
a balance between avoiding hypotension, impaired tissue oxygenation, and inadequate
organ profusion, which may be associated with fluid depletion, and avoiding interstitial
edema and cardiopulmonary complications related to fluid overload. Although the basic
goals of perioperative fluid management have been established, how to attain these goals
remains unclear.
As an alternative to static variables, SVV has been used as a hemodynamic indicator
for predicting fluid responsiveness in patients undergoing mechanical ventilation [14,15].
Accordingly, arterial pulse waveform analysis has been proposed to monitor both cardiac
output (CO) and SVV [16,17]. Regarding echocardiography, it is difficult to manipulate
the probe and to read the screen, which leads to professional human effort being required,
which is a disadvantage. Therefore, a more common approach is fluid response monitoring
through SVV after catheter insertion into the radial artery [7,8]. Generally, SVV is used
to predict fluid responsiveness in patients who are mechanically ventilated. Mechanical
ventilation induces cyclic variations in cardiac preload, which are reflected by cyclic changes
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in systolic arterial pressure, arterial pulse pressure, and left ventricular stroke volume [18].
Although ventilation-related cyclical changes do not induce CO changes in inadequately
filled patients, they can induce significant changes with hypovolemia. Patients with high
SVV values are essentially on the steep portion of Frank Starling’s curve, which plots
the preload effects on stroke volume. SVV is associated with ventilation, with larger
fluctuations being observed in hypovolemia. To minimize these respiratory effects on SVV,
we did not permit spontaneous respiration using muscle relaxant administration and using
a ventilator mode of volume control with PEEP set to 0.
Maintaining the optimal volume state is among the important factors for maintaining
favorable organ perfusion and optimal oxygen supply, which requires accurate volume
state evaluation and prediction. Intraoperative measurements of the effective circulat-
ing blood volume can be obtained using parameters such as blood loss, urine output,
third space, and insensible losses; however, they only serve as a rough estimate [1]. Patients
undergoing major abdominal surgery are recommended to undergo preoperative crystal-
loid loading at 2 mL/kg/h of fasting, with subsequent crystalloid infusion at three to four
times the actual blood loss. Furthermore, the patients frequently received 4 to 8 mL/kg/h
of the crystalloid based on suspected insensible losses, including third spacing and evap-
oration. This could lead to basal crystalloid infusion rates of up to 20 mL/kg/h, which
are frequently titrated to yield urine outputs of 0.5 to 1 mL/kg/h [19]. However, this is
limited since it is insensitive to adequate fluid supply based on the blood vessel state.
To optimize the patient’s blood volume, the effective circulating blood volume should be
properly intraoperatively supplied to balance the blood volume, urine volume, third space,
and insensible loss. Regarding central venous or pulmonary arterial pressure measurement
through the central venous catheter, fluids can be supplied while monitoring cardiovascular
changes and the blood volume status. However, it cannot be applied to all patients given
its invasiveness; moreover, numerous reports have indicated that venous pressure does
not sufficiently reflect blood status [1,20].
There is accumulating evidence showing that intraoperative fluid administration
may affect patient outcomes after major surgery [21]. Specifically, the fluid quantity ad-
ministered significantly influences the incidence of postoperative complications [22,23].
A restrictive fluid strategy contributes to better major-surgery outcomes; furthermore,
goal-directed therapy fluid supply has been shown to improve the outcomes. However,
excessive fluid restriction involving hypovolemia may cause organ dysfunction, increased
postoperative morbidity, and death [24]. This is difficult to determine given the large
inter-practitioner variations in fluid management approaches, which has led to a wide
variation in patient care [25,26]. To mitigate this variation, goal-directed fluid therapy
based on optimizing flow-related variables has been demonstrated as the best approach
for fluid administration in high-risk surgical patients [27,28]. Unfortunately, there has
been low and slow adoption of these strategies by providers and institutions. Among the
challenges impeding implementation is the need for substantial training and vigilance in
applying goal-directed fluid therapy strategies. Even in the study conditions, there is sub-
optimal compliance with treatment protocols [29,30]. Several recent studies have confirmed
the positive effects of using a goal-directed fluid protocol for guiding fluid administra-
tion [31,32]. Although this strategy has been recommended by professional societies in
European countries [33], it is not commonly implemented in clinical practice [34].
This study has several limitations. First, this was a single-center small-scale study;
therefore, there is a need for studies with larger sample sizes to confirm our findings.
Additionally, in laparoscopic surgery, changes in cardiovascular status may affect the SSV
values; therefore, SSV being only applied for open surgeries is a limitation. However,
recently, laparoscopic surgery has become relatively accurate; moreover, the current trend
in surgical procedures is leaning towards laparoscopy or robot-assisted surgery rather than
open abdominal surgery. Therefore, this could be also considered a strength of our study.
Third, the pain intensity and the amount of rescue analgesics after surgery, which are
important factors influencing bowel movement, were higher in the control group compare
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with the SVV group and can be regarded as a bias that may affect the delay in GI function
in addition to intraoperative fluid therapy.
5. Conclusions
In conclusion, compared with the control group, the SVV group presented faster
postoperative soft diet times, which were among the primary objectives regarding the
recovery of bowel function after bowel resection surgery. Furthermore, the SVV group
showed reduced postoperative pain intensity and consumption of rescue analgesics than
the control group.
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